Compare UTHR & PSTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | PSTG |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4B | 25.4B |
| IPO Year | 1999 | 2015 |
| Metric | UTHR | PSTG |
|---|---|---|
| Price | $474.88 | $74.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 19 |
| Target Price | ★ $498.83 | $92.58 |
| AVG Volume (30 Days) | 471.9K | ★ 3.5M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.08 | 4.15 |
| EPS | ★ 26.38 | 0.38 |
| Revenue | $3,128,400,000.00 | ★ $3,483,782,000.00 |
| Revenue This Year | $13.64 | $17.04 |
| Revenue Next Year | $5.78 | $16.37 |
| P/E Ratio | ★ $18.29 | $190.74 |
| Revenue Growth | ★ 13.50 | 13.18 |
| 52 Week Low | $266.98 | $34.51 |
| 52 Week High | $519.99 | $100.59 |
| Indicator | UTHR | PSTG |
|---|---|---|
| Relative Strength Index (RSI) | 40.38 | 56.28 |
| Support Level | $479.59 | $64.27 |
| Resistance Level | $512.74 | $70.80 |
| Average True Range (ATR) | 12.53 | 2.66 |
| MACD | -4.34 | 1.21 |
| Stochastic Oscillator | 2.19 | 82.64 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue, which includes the sale of integrated storage hardware and embedded operating system software; and subscription services revenue, which includes Evergreen Storage subscriptions, a unified subscription that includes Pure as-a-Service, Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.